After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NYSE listed company, RMD falls under the Healthcare sector while operating within the Medical Instruments & Supplies industry segment. The current market capitalization of Resmed Inc is $37.44B. A total of 1.17 million shares were traded on the day, compared to an average of 1.01M shares.
In the most recent transaction, Farrell Michael J. sold 8,009 shares of RMD for 282.85 per share on Oct 07 ’25. After the transaction, the Chief Executive Officer now owns 467,792 company shares. In a previous transaction on Oct 07 ’25, Farrell Michael J. bought 8,009 shares at 282.85 per share.
Among the insiders who bought shares, Ghoshal Kaushik acquired of 4,876 shares on Oct 07 ’25 at a per-share price of $283.42. In another insider transaction, Sandercock Brett sold 3,000 shares at $274.36 per share on Oct 01 ’25. Company shares held by the Chief Financial Officer now total 86,745.
Dividend
Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. Resmed Inc pays an annual dividend of $2.19, resulting in a dividend yield of 0.85%, and it has a price to earnings (P/E) ratio of 26.98.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, RMD has a high of $293.81 and a low of $199.92.
As of this writing, RMD has an earnings estimate of $2.5 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of $2.56 per share and a lower estimate of $2.45. The company reported an EPS of $2.2 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. RMD’s latest balance sheet shows that the firm has $273.71M in Cash & Short Term Investments as of fiscal 2022. There were $917.55M in debt and $689.30M in liabilities at the time. Its Book Value Per Share was $40.77, while its Total Shareholder’s Equity was $3.36B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RMD is Buy with a score of 3.89.
